APRE · Aprea Therapeutics, Inc.
$0.62
+0.01 (+1.19%)
At close · Jul 29
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed May 13, 2026
Market Cap
$7.60M
Shares
12.38M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-26 | 736 | $0.79 | $581 |
| 2026-06-24 | 84 | $0.83 | $70 |
| 2026-06-23 | 27,121 | $0.79 | $21,426 |
| 2026-06-22 | 69 | $0.72 | $50 |
| 2026-06-18 | 535 | $0.78 | $417 |
| 2026-06-17 | 4,430 | $0.73 | $3,234 |
| 2026-06-16 | 161 | $0.70 | $113 |
| 2026-06-15 | 190 | $0.69 | $131 |
| 2026-06-11 | 1,778 | $0.75 | $1,334 |
| 2026-06-10 | 1,073 | $0.74 | $794 |
| 2026-06-09 | 1,852 | $0.73 | $1,352 |
| 2026-06-08 | 8,816 | $0.74 | $6,524 |
| 2026-06-04 | 10,243 | $0.76 | $7,785 |
| 2026-05-29 | 1,537 | $0.93 | $1,429 |
| 2026-05-27 | 5,834 | $0.91 | $5,309 |
| 2026-05-21 | 9,325 | $0.90 | $8,393 |
| 2026-05-19 | 2 | $0.85 | $2 |
| 2026-05-15 | 1 | $0.94 | $1 |
Showing 1–18 of 18 settlements